Neola Medical Competitors and Similar CompaniesClear all

Neola Medical's competitors and similar companies include Esperto Medical, Bactiguard, Cardionomic and Boule Diagnostics.

	Neola Medical Neola Medical (formerly known as GPX Medical) is a company that provides medical diagnostic solutions.	Esperto Medical Esperto Medical is a company that develops vital sign monitoring technologies.	Bactiguard Bactiguard, a medtech company, develops and provides infection prevention solutions.	Cardionomic Cardionomic is a company that provides cardiac treatments intended to be used for treating acute decompensated heart failure.	Boule Diagnostics Boule Diagnostics is a healthcare technology company that develops, manufactures, and sells medical devices for blood analysis.
Founding Date	Founding Date 2016	Founding Date 2018	Founding Date 2005	Founding Date 2011	Founding Date 1992
Type	Type Public	Type Private	Type Public	Type Private	Type Public
Tags	Tags Healthcare healthtech medical devices medical diagnostics medtech	Tags Technology healthtech medical devices medical diagnostics medtech	Tags Healthcare healthtech medical devices medical diagnostics medtech	Tags Healthcare healthtech medical devices medical diagnostics medtech	Tags Healthcare medical devices medical diagnostics medtech
Locations	Locations Lund, SE HQ Palo Alto, US	Locations Irvine, US HQ	Locations Botkyrka, SE HQ	Locations Saint Paul, US HQ	Locations Spånga, SE HQ Moskva, RU Plantation, US
Employees	Employees 8	Employees 129% increase	Employees 147	Employees 4	Employees 2261% decrease
Valuation ($)	Valuation ($) 16.7 m	Valuation ($) N/A	Valuation ($) 139.7 m	Valuation ($) N/A	Valuation ($) 26.2 m
Financial
Revenue (est.)	Revenue (est.) N/A	Revenue (est.) N/A	Revenue (est.) kr215.9m (FY, 2025)	Revenue (est.) N/A	Revenue (est.) kr489.7m (FY, 2025)
Cost of goods	Cost of goods kr274k (FY, 2025)	Cost of goods N/A	Cost of goods kr31.3m (FY, 2025)	Cost of goods N/A	Cost of goods kr253.3m (FY, 2025)
Gross profit	Gross profit (kr229k) (FY, 2025)	Gross profit N/A	Gross profit kr194.3m (FY, 2025)	Gross profit N/A	Gross profit kr259.6m (FY, 2025)
Net income	Net income (kr11m) (FY, 2025)	Net income N/A	Net income (kr7.8m) (FY, 2025)	Net income N/A	Net income (kr3.8m) (FY, 2025)
Funding
Total funding raised	Total funding raised N/A	Total funding raised N/A	Total funding raised $ 14.9m	Total funding raised $ 44.8m	Total funding raised $ 52.9k